GetTopicDetailResponse(id=5d33104369ad, topicName=數(shù)字治療, introduction=數(shù)字治療, content=自閉癥未來要靠數(shù)字治療來解決, image=null, comments=3, allHits=1767, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=10, adminEncryptionId=7a3710, adminName=小小醫(yī)者, createdBy=7a3710, createdName=小小醫(yī)者, createdAvatar=, createdTime=Sun Jul 04 07:28:54 CST 2021, time=2021-07-04, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=110009, tagList=[TagDto(tagId=110009, tagName=數(shù)字治療)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2277662, encodeId=b31e22e766257, content=<a href='/topic/show?id=457f8622190' target=_blank style='color:#2F92EE;'>#自殺風險#</a> <a href='/topic/show?id=5d33104369ad' target=_blank style='color:#2F92EE;'>#數(shù)字治療#</a>, objectTitle=JAMA Network Open：針對高自殺風險住院患者的數(shù)字治療干預隨機臨床試驗, objectType=article, longId=892210, objectId=a5ae8922109e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240705/1720143991774_92910.jpg, objectUrl=/article/show_article.do?id=a5ae8922109e, replyNumber=0, likeNumber=7, createdTime=2025-08-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a5ae8922109e, moduleTitle=JAMA Network Open：針對高自殺風險住院患者的數(shù)字治療干預隨機臨床試驗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a5ae8922109e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2124729, encodeId=eb462124e2942, content=<a href='/topic/show?id=840b5e69950' target=_blank style='color:#2F92EE;'>#數(shù)字療法#</a>明星公司<a href='/topic/show?id=1ecc10583649' target=_blank style='color:#2F92EE;'>#Pear Therapeutics#</a>申請破產，<a href='/topic/show?id=5d33104369ad' target=_blank style='color:#2F92EE;'>#數(shù)字治療#</a>泡沫開始破滅。Pear Therapeutics現(xiàn)已推出三款FDA授權上市的精神醫(yī)學類PDT產品，分別是：用于治療<a href='/topic/show?id=51748e807c7' target=_blank style='color:#2F92EE;'>#藥物濫用#</a>（reSET）、<a href='/topic/show?id=37c110583e78' target=_blank style='color:#2F92EE;'>#**類藥物濫用#</a>（ reSET-O）和失眠及其引發(fā)的<a href='/topic/show?id=0a0b5496306' target=_blank style='color:#2F92EE;'>#抑郁#</a>（Somryst）。, objectTitle=數(shù)字療法明星公司Pear申請破產，數(shù)字治療泡沫開始破滅, objectType=article, longId=766359, objectId=7142e663590f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230313/29d8fc61122645acb64672616f692054.jpg, objectUrl=/article/show_article.do?id=7142e663590f, replyNumber=0, likeNumber=156, createdTime=2023-04-10, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7142e663590f, moduleTitle=數(shù)字療法明星公司Pear申請破產，數(shù)字治療泡沫開始破滅, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7142e663590f)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2094016, encodeId=f0712094016ab, content=<a href='/topic/show?id=485b650109e' target=_blank style='color:#2F92EE;'>#注意力缺陷#</a>/<a href='/topic/show?id=9baa1049608d' target=_blank style='color:#2F92EE;'>#小兒多動癥#</a>（<a href='/topic/show?id=459f19e855' target=_blank style='color:#2F92EE;'>#ADHD#</a>）是全世界兒童、青少年和成人中最普遍的神經發(fā)育障礙之一。多模式治療，包括藥物治療、<a href='/topic/show?id=1b11511621c' target=_blank style='color:#2F92EE;'>#心理治療#</a>和<a href='/topic/show?id=bc08104961ba' target=_blank style='color:#2F92EE;'>#心理教育#</a>。因此，不同的專家主張使用替代療法，如<a href='/topic/show?id=87dc10496276' target=_blank style='color:#2F92EE;'>#神經反饋#</a>、<a href='/topic/show?id=5d33104369ad' target=_blank style='color:#2F92EE;'>#數(shù)字治療#</a>，和/或營養(yǎng)補充劑。在營養(yǎng)補充劑中，<a href='/topic/show?id=6286884e621' target=_blank style='color:#2F92EE;'>#藏紅花#</a>最近被推測為治療<a href='/topic/show?id=bf444306e0f' target=_blank style='color:#2F92EE;'>#多動癥#</a>最有趣的替代療法之一。, objectTitle=藏紅花提取物對兒童和青少年注意力缺陷/多動癥（ADHD）的治療效果:一項臨床效果研究, objectType=article, longId=743522, objectId=3cd8e43522f8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/0bb26bb06c749da377c24660a.jpg, objectUrl=/article/show_article.do?id=3cd8e43522f8, replyNumber=0, likeNumber=190, createdTime=2022-10-16, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cd8e43522f8, moduleTitle=藏紅花提取物對兒童和青少年注意力缺陷/多動癥（ADHD）的治療效果:一項臨床效果研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3cd8e43522f8)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=995975, encodeId=08ee9959e5ab, content=<a href='/topic/show?id=4266863e7bd' target=_blank style='color:#2F92EE;'>#自閉癥#</a>未來要靠<a href='/topic/show?id=5d33104369ad' target=_blank style='color:#2F92EE;'>#數(shù)字治療#</a>來解決, objectTitle=Lancet Psychiatry：自閉癥患者更有可能使用娛樂性藥物進行自我治療, objectType=article, longId=213697, objectId=d5dc21369e31, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202173/1625306486576_1608702.png, objectUrl=/article/show_article.do?id=d5dc21369e31, replyNumber=0, likeNumber=217, createdTime=2021-07-04, rootId=0, userName=小小醫(yī)者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5dc21369e31, moduleTitle=Lancet Psychiatry：自閉癥患者更有可能使用娛樂性藥物進行自我治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d5dc21369e31)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
小小醫(yī)者
2021-07-04
